During the past decade, Department of Hematology-Oncology, National University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology-Oncology, National University Hospital" #1 collaborator was "National University of Singapore" with 1 trials as a collaborator and "Singapore General Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology-Oncology, National University Hospital" are "Acute Myeloid Leukemia" (1 trials), "Glioma, Astrocytic" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Department of Hematology-Oncology, National University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Hematology-Oncology, National University Hospital" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CD8+ T-cell depleted donor lymphocyte infusion" (1 trials), "QPOP category 1" (1 trials) and "QPOP category 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology-Oncology, National University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hematology-Oncology, National University Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Hematology-Oncology, National University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology-Oncology, National University Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".